(Q33369463)

English

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies (English)
0 references
Barbara MacGregor-Cortelli

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit